Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharath R Ravichandran

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2021
The Impact of Atherosclerotic Cardiovascular Risk on Graft Failure in Deceased-Donor Renal TransplantationGrace Hsu, Tracy M Sparkes, Brent N Reed, et al.
Journal of Pharmacy Practice|July 22, 2021
The Impact of Treatment Delay on Hepatitis C Liver Transplant OutcomesIan A Booth, Jacqueline E Clark, John C LaMattina, et al.
Clinical Transplantation|September 4, 2020
Survival benefit of renal transplantation in octogenariansBharath R Ravichandran, Tracy M Sparkes, Brian M Masters, et al.
International Journal of Clinical Pharmacy|February 23, 2018
Collaborative practice agreement in solid organ transplantationBharath R Ravichandran, Matthew W Gillespie, Tracy M Sparkes, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 12, 2022
Impact of high MELD scores on CMV viremia following liver transplantationSari R Freedman, Kenneth Saunders, Michael E Plazak, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft functionSari R Freedman, Bharath R Ravichandran, Brian M Masters, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Progress in Transplantation (Aliso Viejo, Calif.)|June 16, 2021
The Impact of Atherosclerotic Cardiovascular Risk on Graft Failure in Deceased-Donor Renal TransplantationGrace Hsu, Tracy M Sparkes, Brent N Reed, et al.
Journal of Pharmacy Practice|July 22, 2021
The Impact of Treatment Delay on Hepatitis C Liver Transplant OutcomesIan A Booth, Jacqueline E Clark, John C LaMattina, et al.
Clinical Transplantation|September 4, 2020
Survival benefit of renal transplantation in octogenariansBharath R Ravichandran, Tracy M Sparkes, Brian M Masters, et al.
International Journal of Clinical Pharmacy|February 23, 2018
Collaborative practice agreement in solid organ transplantationBharath R Ravichandran, Matthew W Gillespie, Tracy M Sparkes, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 12, 2022
Impact of high MELD scores on CMV viremia following liver transplantationSari R Freedman, Kenneth Saunders, Michael E Plazak, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2019
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft functionSari R Freedman, Bharath R Ravichandran, Brian M Masters, et al.
Pageof 1